Metropolitan Life Insurance Company (MetLife)’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,642	Closed	-$20.2K	–	2517
2022 Q4	$20.2K	Buy	1,642 +343	+26%	+$8.17K	﹤0.01%	2006
2022 Q3	$42.6K	Buy	1,299 +351	+37%	+$9.92K	﹤0.01%	1565
2022 Q2	$17.9K	Hold	948	–	–	﹤0.01%	2096
2022 Q1	$16.6K	Buy	+948	New	+$19.5K	﹤0.01%	2175

Metropolitan Life Insurance Company (MetLife)'s CINC Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,642 shares — an estimated $20.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $42.6K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,642 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $20.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s CinCor Pharma, Inc. Common Stock position peaked at $42.6K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.